KemPharma Stock Price (NASDAQ:KMPH)

Add to My Stocks
$4.6 $0.1 (2.22%) KMPH stock closing price Apr 28, 2017 (Closing)
Prev Close* : $4.50
Market Cap:
$67.38M
Day Low: $4.52
52 Week Low: $2.90
Open: $4.55
Volume: 4543
Day High: $4.61
52 Week High: $17.14
Dividend:
N/A

Latest Stock Market News

Latest Articles

KemPharma News - From Partners

KemPharm, Inc. to Report Third Quarter 2016 Results   by Globe Newswire on Nov 01, 2016

KMPH Stockcharts

View KMPH PE ratio, PS ratio stocks charts and compare with peers.
KMPH Chart
Note: Compare KemPharma stock price history with the index and industry peers.

KMPH Industry Peers

Company Price Change (%)
Sierra Oncology (SRRA)1.390.02 (1.42%)
Lipocine (LPCN)4.240.13 (3.16%)
Collegium Pharma (COLL)9.810.21 (2.1%)
Acura Pharma (ACUR)0.520.01 (1.89%)
Egalet (EGLT)3.820.26 (6.37%)
Depomed (DEPO)11.990.16 (1.32%)
Pain Therapeutics (PTIE)0.850.06 (7.59%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Cempra (CEMP)4.30.45 (11.69%)
United Therapeutics (UTHR)125.75.2 (4.32%)
Nutraceutical International (NUTR)31.70.95 (3.09%)
La Jolla Pharma (LJPC)290.82 (2.91%)
Grifols (GRFS)21.710.54 (2.55%)
Infinity Pharma (INFI)2.150.05 (2.38%)
Genocea Biosciences (GNCA)6.390.14 (2.24%)
Top gainers from Medical-Drugs industry
* As of Apr 29, 2017
CompanyPriceChange (%)
Egalet (EGLT)3.820.26 (6.37%)
MADRIGAL PHARMA (MDGL)16.51 (5.71%)
Adamis Pharma (ADMP)3.70.2 (5.13%)
MediWound (MDWD)60.3 (4.76%)
GlycoMimetics (GLYC)4.30.21 (4.66%)
Galectin Therapeutics (GALT)3.060.12 (3.77%)
AVADEL PHARMA (AVDL)9.490.33 (3.36%)
Top losers from Medical-Drugs industry
* As of Apr 29, 2017

KemPharma Financial Statements

income statement2016201520142013
Net Sales Or Revenues----
Net Income-16.51M-54.66M-24.45M-5.22M
Total Operating Expense37.48M22.81M16.43M4.71M
view KemPharm Inc income statement
balance sheet2016201520142013
Total Assets84.88M55.72M13.71M2.42M
Total Liabilities103.58M65.84M38.01M8.14M
Shareholders Equity-18.69M-10.12M-24.3M-24.26M
view KemPharm Inc balance sheet
cash flow statement2016201520142013
Net Increase (Decrease) In Assets Liabilities3.32M0.08M1.45M0.12M
Net Cash From (Used By) Operating Activities-29.77M-20.26M-14.67M-4.31M
Increase (Decrease) In Prop Plant And Equipment-0.64M-0.13M-0.04M-0.04M
view KemPharm Inc cashflow statement

KemPharma Stock Message Board

KemPharma stock price ended the last trading day at 4.6. Looking at KemPharma market capitalization, which currently stands at 65.91M, we can say that KMPH stock is a Micro cap stock. KemPharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that KemPharma is worth a lot, it will most likely be reflected in an inflated KemPharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume number in KemPharma stock quote data shows the number of shares traded. For Ex: 4543 KemPharma shares were traded as of last trading day, as seen from KemPharma stock chart. KemPharma stock price history, gives the entire historical data for KMPH stock.